The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency
Open accessAbstract
Ikaros/IKZF1 is an essential transcription factor expressed throughout hematopoiesis. IKZF1 is implicated in lymphocyte and myeloid differentiation and negative regulation of cell proliferation. In humans, somatic mutations in IKZF1 have been linked to the development of B cell acute lymphoblastic leukemia (ALL) in children and adults. Recently, heterozygous germline IKZF1 mutations have been identified in patients with a B cell immune deficiency mimicking common variable immunodeficiency. These mutations demonstrated incomplete penetrance and led to haploinsufficiency. Herein, we report 7 unrelated patients with a novel early-onset combined immunodeficiency associated with de novo germline IKZF1 heterozygous mutations affecting amino acid N159 located in the DNA-binding domain of IKZF1. Different bacterial and viral infections were diagnosed, but Pneumocystis jirovecii pneumonia was reported in all patients. One patient developed a T cell ALL. This immunodeficiency was characterized by innate and adaptive immune defects, including low numbers of B cells, neutrophils, eosinophils, and myeloid dendritic cells, as well as T cell and monocyte dysfunctions. Notably, most T cells exhibited a naive phenotype and were unable to evolve into effector memory cells. Functional studies indicated these mutations act as dominant negative. This defect expands the clinical spectrum of human IKZF1-associated diseases from somatic to germline, from haploinsufficient to dominant negative.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lenalidomide monotherapy has produced CR rates of almost 20% in the settings of both newly diagnosed and R/R AML102,103.”
From Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide (2021) · cites this paper as [102]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 46,047
Deciphering key features in protein structures with the new ENDscript server
Robert, X., & Gouet, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku316 · Cited by 7,053
Comparative Protein Structure Modeling of Genes and Genomes
Martí-Renom, M. A., Stuart, A. C., Fiser, A., Sánchez, R., Melo, F., & Šali, A. (2000) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.29.1.291 · Cited by 3,169
Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
Mullighan, C. G., Su, X., Zhang, J., Radtke, I., Phillips, L. A. A., Miller, C. B., Ma, J., Liu, W., Cheng, C., Schulman, B. A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808253 · Cited by 1,422
The ikaros gene is required for the development of all lymphoid lineages
Georgopoulos, K., Bigby, M., Wang, J.-H., Molnar, A., Wu, P., Winandy, S., & Sharpe, A. (1994) · Cell · doi:10.1016/0092-8674(94)90407-3 · Cited by 985
Lymphocyte subsets in healthy children from birth through 18 years of age
Shearer, W. T., Rosenblatt, H. M., Gelman, R. S., Oyomopito, R. A., Plaeger, S. F., Stiehm, E. R., Wara, D. W., Douglas, S. D., Luzuriaga, K., McFarland, E. J., et al. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.07.003 · Cited by 827
GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity
Spinner, M. A., Sanchez, L. A., Hsu, A. P., Shaw, P. A., Zerbe, C. S., Calvo, K. R., Arthur, D. C., Gu, W., Gould, C. M., Brewer, C. C., et al. (2013) · Blood · doi:10.1182/blood-2013-07-515528 · Cited by 713
Self-citationWang, J., Nichogiannopoulou, A., Wu, L. J., Sun, L., Sharpe, A. H., Bigby, M. E., & Georgopoulos, K. (1996) · Immunity · doi:10.1016/s1074-7613(00)80269-1 · Cited by 614
Ikaros DNA-Binding Proteins Direct Formation of Chromatin Remodeling Complexes in Lymphocytes
Kim, J., Sif, S., Jones, B., Jackson, A., Koipally, J., Heller, E., Winandy, S., Viel, A., Sawyer, A., Ikeda, T., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80034-5 · Cited by 587
Cited by
Sorted by citations
Tangye, S. G., Al–Herz, W., Bousfiha, A. A., Chatila, T. A., Cunningham‐Rundles, C., Etzioni, A., Franco, J. L., Holland, S. M., Klein, C., Morio, T., et al. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00737-x · Cited by 1,221
Self-citationCurrent genetic landscape in common variable immune deficiency
Abolhassani, H., Hammarström, L. L. G., & Cunningham‐Rundles, C. (2020) · Blood · doi:10.1182/blood.2019000929 · Cited by 185
Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy
Bonazzi, S., d’Hennezel, E., Beckwith, R. E. J., Xu, L., Fazal, A., Magracheva, A., Ramesh, R., Cernijenko, A., Antonakos, B., Bhang, H.-E. C., et al. (2023) · Cell Chemical Biology · doi:10.1016/j.chembiol.2023.02.005 · Cited by 167
Hadjadj, J., Aladjidi, N., Fernandes, H., Leverger, G., Magérus, A., Mazerolles, F., Stolzenberg, M., Jacques, S., Pïcard, C., Rosain, J., et al. (2019) · Blood · doi:10.1182/blood-2018-11-887141 · Cited by 159
Self-citationAdvances in germline predisposition to acute leukaemias and myeloid neoplasms
Klco, J. M., & Mullighan, C. G. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-00315-z · Cited by 163
Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide
Jan, M., Sperling, A. S., & Ebert, B. L. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00479-z · Cited by 137
Common variable immune deficiency: Dissection of the variable
Cunningham‐Rundles, C. (2018) · Immunological Reviews · doi:10.1111/imr.12728 · Cited by 94
Hoshino, A., Boutboul, D., Zhang, Y., Kuehn, H. S., Hadjadj, J., Özdemir, N., Celkan, T. T., Walz, C., Pïcard, C., Lenoir, C., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abi7160 · Cited by 80
Self-citationRecent advances in genetic predisposition to pediatric acute lymphoblastic leukemia
Bloom, M., Maciaszek, J. L., Clark, M. E., Pui, C., & Nichols, K. E. (2019) · Expert Review of Hematology · doi:10.1080/17474086.2020.1685866 · Cited by 79
Cheng, W., Li, J., Zhu, Y., Lin, X., Wen, L., Zhang, F., Zhang, Y., Zhao, M., Fang, H., Wang, S., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211429119 · Cited by 78
Self-citationStrand, J. M., Gul, K. A., Erichsen, H. C., Lundman, E., Berge, M. C., Trømborg, A. K., Sørgjerd, L. K., Ytre-Arne, M. E., Hogner, S., Halsne, R., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01417 · Cited by 73
Hetemäki, I., Kaustio, M., Kinnunen, M., Heikkilä, N., Keskitalo, S., Nowlan, K., Miettinen, S., Sarkkinen, J., Glumoff, V., Andersson, N., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abe3454 · Cited by 71
Haas, O. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03136 · Cited by 70
A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS
Yamashita, M., Kuehn, H. S., Okuyama, K., Okada, S., Inoue, Y., Mitsuiki, N., Imai, K., Takagi, M., Kanegane, H., Takeuchi, M., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00951-z · Cited by 66
Self-citationTranscription factor mutations as a cause of familial myeloid neoplasms
Churpek, J. E., & Bresnick, E. H. (2019) · Journal of Clinical Investigation · doi:10.1172/jci120854 · Cited by 60
Inborn errors of human IKAROS: LOF and GOF variants associated with primary immunodeficiency
Kuehn, H. S., Boast, B., & Rosenzweig, S. D. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac109 · Cited by 60
Self-citationTranscriptomic classes of BCR-ABL1 lymphoblastic leukemia
Kim, J. C., Chan‐Seng‐Yue, M., Ge, S., Zeng, A. G. X., Ng, K., Gan, O. I., García‐Prat, L., Figueroa, E. F., Woo, T., Zhang, A. X. W., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01429-4 · Cited by 61
Aubrey, B. J., Cutler, J. A., Bourgeois, W., Donovan, K. A., Gu, S. S., Hatton, C., Perlee, S. C., Perner, F., Rahnamoun, H., Theall, A. C. P., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00366-1 · Cited by 58
Germline IKAROS dimerization haploinsufficiency causes hematologic cytopenias and malignancies
Kuehn, H. S., Niemela, J. E., Stoddard, J. L., Mannurita, S. C., Shahin, T., Goel, S., Hintermeyer, M. K., Heredia, R. J., Garofalo, M. E., Lucas, L., et al. (2020) · Blood · doi:10.1182/blood.2020007292 · Cited by 57
Self-citationIdentification of germline monoallelic mutations in IKZF2 in patients with immune dysregulation
Shahin, T., Mayr, D., Shoeb, M. R., Kuehn, H. S., Hoeger, B., Giuliani, S., Gawriyski, L. M., Petronczki, Ö. Y., Hadjadj, J., Bal, S. K., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021006367 · Cited by 58
Self-citationEskandarian, Z., Fliegauf, M., Bulashevska, A., Proietti, M., Hague, R., Smulski, C. R., Schubert, D., Warnatz, K., & Grimbacher, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00568 · Cited by 56
Human genetics of life-threatening influenza pneumonitis
Zhang, Q. (2020) · Human Genetics · doi:10.1007/s00439-019-02108-3 · Cited by 54
Guiding T lymphopoiesis from pluripotent stem cells by defined transcription factors
Guo, R., Hu, F., Weng, Q., Lv, C., Wu, H., Liu, L., Li, Z., Zeng, Y., Bai, Z., Zhang, M., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0251-7 · Cited by 52
Xue, T., Kong, X., & Ma, L. (2023) · Journal of Fungi · doi:10.3390/jof9080812 · Cited by 55
Toward prevention of childhood ALL by early-life immune training
Hauer, J., Fischer, U., & Borkhardt, A. (2021) · Blood · doi:10.1182/blood.2020009895 · Cited by 54
Understanding mast cell heterogeneity at single cell resolution
Cildir, G., Yip, K. H., Pant, H., Tergaonkar, V., Lopez, A. F., & Tumes, D. J. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.04.004 · Cited by 46
Gocho, Y., & Yang, J. J. J. (2019) · Blood · doi:10.1182/blood.2018852400 · Cited by 45
Kuehn, H. S., Chang, J., Yamashita, M., Niemela, J. E., Zou, C., Okuyama, K., Harada, J., Stoddard, J. L., Nunes-Santos, C. J., Boast, B., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20211118 · Cited by 45
Self-citationKuehn, H. S., Nunes-Santos, C. J., & Rosenzweig, S. D. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00936-x · Cited by 43
Self-citationCell Fate Decisions: The Role of Transcription Factors in Early B-cell Development and Leukemia
Fischer, U., Yang, J. J. J., Ikawa, T., Hein, D., Vicente‐Dueñas, C., Borkhardt, A., & Sánchez-García, I. (2020) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-20-0011 · Cited by 48
Shahin, T., Kuehn, H. S., Shoeb, M. R., Gawriyski, L. M., Giuliani, S., Repiščák, P., Hoeger, B., Petronczki, Ö. Y., Bal, S. K., Zoghi, S., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abe3981 · Cited by 44
Self-citationCippitelli, M., Stabile, H., Kosta, A., Petillo, S., Gismondi, A., Santoni, A., & Fionda, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031103 · Cited by 42
Update on Infections in Primary Antibody Deficiencies
Demirdağ, Y. Y., & Gupta, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.634181 · Cited by 42
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia
Li, J., Dai, Y., Wu, L., Zhang, M., Ouyang, W., Huang, J., & Chen, S. (2021) · Frontiers of Medicine · doi:10.1007/s11684-020-0821-6 · Cited by 44
Self-citationThe link between rheumatic disorders and inborn errors of immunity
Sogkas, G., & Witte, T. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104501 · Cited by 42
Germline mutations in the transcription factor IKZF5 cause thrombocytopenia
Lentaigne, C., Greene, D. J., Sivapalaratnam, S., Favier, R., Seyres, D., Thys, C., Grassi, L., Mangles, S., Sibson, K. R., Stubbs, M. J., et al. (2019) · Blood · doi:10.1182/blood.2019000782 · Cited by 44
Okano, T., Imai, K., Naruto, T., Okada, S., Yamashita, M., Yeh, T.-W., Ono, S., Tanaka, K., Okamoto, K., Tanita, K., et al. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00798-3 · Cited by 31
Self-citationLionakis, M. S. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000593 · Cited by 32
Cancer Trends in Inborn Errors of Immunity: A Systematic Review and Meta-Analysis
Fekrvand, S., Abolhassani, H., Esfahani, Z. H., Fard, N. N. G., Amiri, M., Salehi, H., Almasi‐Hashiani, A., Saeedi‐Boroujeni, A., Fathi, N., Mohtashami, M., et al. (2024) · Journal of Clinical Immunology · doi:10.1007/s10875-024-01810-w · Cited by 31
Kuehn, H. S., Nunes-Santos, C. J., & Rosenzweig, S. D. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1901582 · Cited by 30
Self-citationInborn errors of immunity—recent advances in research on the pathogenesis
Yamashita, M., Inoue, K., Okano, T., & Morio, T. (2021) · Inflammation and Regeneration · doi:10.1186/s41232-021-00159-6 · Cited by 30
Kellner, E. S., Krupski, C., Kuehn, H. S., Rosenzweig, S. D., Yoshida, N., Kojima, S., Boutboul, D., Latour, S., Barlogis, V., Galambrun, C., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.03.025 · Cited by 28
Self-citationCellular signaling and epigenetic regulation of gene expression in leukemia
Gowda, C. S., Song, C., Ding, Y., Iyer, S., Dhanyamraju, P. K., McGrath, M., Bamme, Y., Soliman, M., Kane, S., Payne, J. L., et al. (2019) · Advances in Biological Regulation · doi:10.1016/j.jbior.2019.100665 · Cited by 27
Trottier, A. M., & Godley, L. A. (2020) · British Journal of Haematology · doi:10.1111/bjh.17247 · Cited by 27
Multiple functions of Ikaros in hematological malignancies, solid tumor and autoimmune diseases
Chen, Q., Shi, Y., Chen, Y., Ji, T., Li, Y., & Yu, L. (2018) · Gene · doi:10.1016/j.gene.2018.10.045 · Cited by 27
Chen, Z., Dhruv, H., Zhang, X., Rej, R. K., Bai, L., McEachern, D., Kirchhoff, P. D., Nagilla, R., Jolivette, L. J., Rice, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58431-z · Cited by 28
IKAROS Family Zinc Finger 1–Associated Diseases in Primary Immunodeficiency Patients
Nunes-Santos, C. J., Kuehn, H. S., & Rosenzweig, S. D. (2020) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2020.04.004 · Cited by 29
Self-citationGuenther, C., Faisal, I., Fusciello, M., Sokolova, M., Harjunpää, H., Ilander, M. M., Tallberg, R., Vartiainen, M. K., Alon, R., González, J. M., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0094 · Cited by 26
IKZF1 Loss-of-Function Variant Causes Autoimmunity and Severe Familial Antiphospholipid Syndrome
Dieudonné, Y., Guffroy, A., Vollmer, O., Carapito, R., & Korganow, A. (2019) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00643-2 · Cited by 25
Ikaros-Associated Diseases: From Mice to Humans and Back Again
Boast, B., Nunes-Santos, C. D. J., Kuehn, H. S., & Rosenzweig, S. D. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.705497 · Cited by 25
Self-citationGuenther, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.809590 · Cited by 24
Human and mouse early B cell development: So similar but so different
Korzhenevich, J., Janowska, I., van der Burg, M., & Rizzi, M. (2023) · Immunology Letters · doi:10.1016/j.imlet.2023.07.004 · Cited by 23
Genes at the Crossroad of Primary Immunodeficiencies and Cancer
Derpoorter, C., Bordon, V., Laureys, G., Haerynck, F., & Lammens, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02544 · Cited by 23
IKZF1 alterations predict poor prognosis in adult and pediatric T-ALL
Simonin, M., Lhermitte, L., Dourthe, M.-É., Lengliné, É., Graux, C., Grardel, N., Cayuela, J., Arnoux, I., Gandemer, V., Ifrah, N., et al. (2020) · Blood · doi:10.1182/blood.2020007959 · Cited by 23
Self-citationCD8+T Cell-Related Gene Biomarkers in Macular Edema of Diabetic Retinopathy
Huang, J., & Zhou, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.907396 · Cited by 21
Inborn errors of IKAROS and AIOLOS
Yamashita, M., & Morio, T. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.06.010 · Cited by 22
IKAROS: from chromatin organization to transcriptional elongation control
Affar, M., Bottardi, S., Quansah, N., Lemarié, M., Ramòn, A. C., Affar, E. B., & Milot, É. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01212-2 · Cited by 20
Liu, K., Wu, Z., Chu, J., Yang, L., & Wang, N. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108913 · Cited by 21
Transcription factor networks link B-lymphocyte development and malignant transformation in leukemiaPreprint
Sigvardsson, M. (2023) · Genes & Development · doi:10.1101/gad.349879.122 · Cited by 24
Vu, T., Straube, J., Porter, A. H., Bywater, M. J., Song, A., Ling, V., Cooper, L. T., Pali, G., Bruedigam, C., Jacquelin, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16840-2 · Cited by 20
Bloom, M., Oak, N., Baskin-Doerfler, R., Feng, R., Iacobucci, I., Baviskar, P. S., Zhao, X., Stroh, A. N., Li, C., Ozark, P. A., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022009313 · Cited by 18
Kuehn, H. S., Sakovich, I. S., Niemela, J. E., Silva, A. A. G., Stoddard, J. L., Polyakova, E. A., Sole, A. E., Aleshkevich, S. N., Углова, Т. А., Belevtsev, M. V., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci172573 · Cited by 19
Self-citationFamilial Immune Thrombocytopenia Associated With a Novel Variant in IKZF1
Sriaroon, P., Chang, Y., Ujházi, B., Csomós, K., Joshi, H. R., Zhou, Q., Close, D. W., Walter, J. E., & Kumánovics, A. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00139 · Cited by 19
IKZF1 and UBR4 gene variants drive autoimmunity and Th2 polarization in IgG4-related disease
Liu, Q., Zheng, Y., Sturmlechner, I., Jain, A. K., Own, M., Yang, Q., Zhang, H., Vairo, F. P. E., Cerosaletti, K. M., Buckner, J. H., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178692 · Cited by 21
Genetic susceptibility to fungal infection in children
Ochoa, S., Constantine, G. M., & Lionakis, M. S. (2020) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000948 · Cited by 18
The New “Wholly Trinity” in the Diagnosis and Management of Inborn Errors of Immunity
Abraham, R. S., & Butte, M. J. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.11.044 · Cited by 18
Assessment of kinship detection using RNA-seq data
Blay, N., Casas, E., Galván‐Femenía, I., Graffelman, J., de Cid, R., & Vavouri, T. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz776 · Cited by 16
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
Eckardt, J., Stasik, S., Röllig, C., Petzold, A., Sauer, T., Scholl, S., Hochhaus, A., Crysandt, M. M., Brümmendorf, T. H., Naumann, R., et al. (2023) · Leukemia · doi:10.1038/s41375-023-02061-1 · Cited by 15
Sin, J. H., Sucharov, J., Kashyap, S., Wang, Y., Proekt, I., Liu, X., Parent, A. V., Gupta, A. R., Kastner, P., Chan, S. H., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.abq3109 · Cited by 15
Multifaceted roles of IKZF1 gene, perspectives from bench to bedside
Feng, L., Zhang, H., & Liu, T. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1383419 · Cited by 15
Catchet-MS identifies IKZF1-targeting thalidomide analogues as novel HIV-1 latency reversal agents
Ne, E., Crespo, R., Izquierdo-Lara, R. W., Rao, S., Koçer, S., Górska, A., van Staveren, T., Kan, T. W., van de Vijver, D. A. M. C., Dekkers, D. H. W., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac407 · Cited by 15
AIOLOS Variants Causing Immunodeficiency in Human and Mice
Yamashita, M., & Morio, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.866582 · Cited by 14
Identification of IKZF1 genetic mutations as new molecular subtypes in acute myeloid leukaemia
Wang, Y., Cheng, W., Zhang, Y., Zhang, Y., Sun, T., Zhu, Y., Yin, W. H., Zhang, J., Li, J., & Shen, Y. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1309 · Cited by 13
Harjunpää, H., Somermäki, R., Rubio, G. S., Fusciello, M., Feola, S., Faisal, I., Nieminen, A. I., Wang, L., Asens, M. L., Zhao, H., et al. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2369373 · Cited by 14
Dominant negative ADA2 mutations cause ADA2 deficiency in heterozygous carriers
Wouters, M., Ehlers, L., Eynde, W. V., Kars, M. E., Delafontaine, S., Kienapfel, V., Dzhus, M., Schrijvers, R., Haes, P. D., Struyf, S., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20250499 · Cited by 14
Yilmaz, E. A., Kuehn, H. S., Odakir, E., Niemela, J. E., Özcan, A., Eken, A., Rohlfs, M., Cansever, M., Gök, V., Aydın, F., et al. (2020) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000001976 · Cited by 12
Self-citationAIOLOS-Associated Inborn Errors of Immunity
Yamashita, M., & Morio, T. (2024) · Journal of Clinical Immunology · doi:10.1007/s10875-024-01730-9 · Cited by 11
Okuyama, K., Yamashita, M., Koumoundourou, A., Wiegreffe, C., Ohno‐Oishi, M., Murphy, S. J. H., Zhao, X., Yoshida, H., Ebihara, T., Satoh‐Takayama, N., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01997-5 · Cited by 11
Min, Q., Meng, X., & Wang, J. O. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3532-1_10 · Cited by 11
Groth, D., Lakkaraja, M. M., Ferreira, J. O., Feuille, E. J., Bassetti, J. A., & Kaicker, S. M. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00781-y · Cited by 11
Defining the vascular niche of human adipose tissue across metabolic states
AlZaim, I., Hassan, M. N., Schröter, M., Mannino, L., Dragicevic, K., Sjogaard, M. B., Festa, J., Dokshokova, L., Weinbrenner, S., Ayllón, B. T., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01475-2 · Cited by 10
Klangkalya, N., Stoddard, J. L., Niemela, J. E., Sponaugle, J., Greenwell, I. B., Reigh, E. L., Kuehn, H. S., Kanakry, J. A., Rosenzweig, S. D., & Dimitrova, D. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.109922 · Cited by 10
Self-citationHoshino, A., Toyofuku, E., Mitsuiki, N., Yamashita, M., Okamoto, K., Yamamoto, M., Kanda, K., Yamato, G., Keino, D., Yoshimoto-Suzuki, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.784901 · Cited by 10
Self-citationOf Mycelium and Men: Inherent Human Susceptibility to Fungal Diseases
Vinh, D. C. (2023) · Pathogens · doi:10.3390/pathogens12030456 · Cited by 11
Wang, B., Duan, J., & Zhou, L. (2021) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001041 · Cited by 10
Inborn errors of regulatory T-cell differentiation and function
Öktelik, F. B., Luo, Y., Benamar, M., & Chatila, T. A. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.07.001 · Cited by 9
Al‐Hakim, A., Kačar, M., & Savic, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061717 · Cited by 9
Zhang, X., Dhruv, H., Deng, Q., Tudor, M., Bechtel, N., Nagilla, R., Jolivette, L. J., Rice, C., Orth, P., Behshad, E., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00668 · Cited by 9
Kuijpers, T. W., Tromp, S. A. M., van Leeuwen, E. M. M., & de Bree, G. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.865838 · Cited by 8
Hess, I., Sagar, O’Meara, C. P., Grün, D., Schorpp, M., & Boehm, T. L. J. (2022) · Scientific Reports · doi:10.1038/s41598-022-25978-6 · Cited by 8
Loss-of-phosphorylation of IKZF1 results in gain-of-function associated with immune dysregulation
Hoshino, A., Picard, B. H., Polychronopoulou, S., Kelaïdi, C., Azarnoush, S., Kracker, S., Rieux‐Laucat, F., Boutboul, D., & Latour, S. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.01.029 · Cited by 8
Self-citationKuehn, H. S., Gloude, N. J., Dimmock, D., Tokita, M., Wright, M. S., Rosenzweig, S. D., & Collins, C. A. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01035-1 · Cited by 8
Self-citationThe telomere complex and the origin of the cancer stem cell
Torres-Montaner, A. (2021) · Biomarker Research · doi:10.1186/s40364-021-00339-z · Cited by 8
Updates of cancer hallmarks in patients with inborn errors of immunity
Wang, Y., & Abolhassani, H. (2022) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000863 · Cited by 8
Tao, H., Li, Z., Mei, Y., Li, X., Lou, H., Dong, L., & Zhou, L. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106832 · Cited by 8
IKZF2 Degradation: It′s Time to Take into Account it When Designing Cereblon‐Based PROTACs
Li, M. (2024) · ChemBioChem · doi:10.1002/cbic.202400365 · Cited by 7
Impaired tissue homing by the Ikzf3N159S variant is mediated by interfering with Ikaros function
Chang, J., Yamashita, M., Padhi, A. K., Zhang, K. Y. J., & Taniuchi, I. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1239779 · Cited by 7
Self-citationGuiding T lymphopoiesis from pluripotent stem cells by defined transcription factorsPreprint
Guo, R., Hu, F., Weng, Q., Lv, C., Wu, H., Liu, L., Li, Z., Zeng, Y., Bai, Z., Zhang, M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/660977 · Cited by 7
Pathogenic germline IKZF1 variant alters hematopoietic gene expression profilesPreprint
Brodie, S. A., Khincha, P. P., Giri, N., Bouk, A. J., Steinberg, M. K., Dai, J., Jessop, L., Donovan, F. X., Chandrasekharappa, S. C., de Andrade, K. C., et al. (2021) · Molecular Case Studies · doi:10.1101/mcs.a006015 · Cited by 7
Zhang, X., Deng, Q., Dhruv, H., Tudor, M., Nagilla, R., Jolivette, L. J., Rice, C., Orth, P., Behshad, E., Strickland, C. O., et al. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130263 · Cited by 6
Metadata
- Authors
- Boutboul, D., Kuehn, H. S., Van de Wyngaert, Z., Niemela, J. E., Callebaut, I., Stoddard, J., Lenoir, C., Barlogis, V., Farnarier, C., Vely, F., Yoshida, N., Kojima, S., Kanegane, H., Hoshino, A., Hauck, F., Lhermitte, L., Asnafi, V., Roehrs, P., Chen, S., Verbsky, J. W., Calvo, K. R., Husami, A., Zhang, K., Roberts, J., Amrol, D., Sleaseman, J., Hsu, A. P., Holland, S. M., Marsh, R., Fischer, A., Fleisher, T. A., Picard, C., Latour, S., & Rosenzweig, S. D.
- Affiliations
- Inserm (FR)
- National Institutes of Health (US)
- Centre National de la Recherche Scientifique (FR)
- Hôpital de la Timone (FR)
- Assistance Publique Hôpitaux de Marseille (FR)
- Japanese Red Cross Nagoya Daiichi Hospital (JP)
- Nagoya University (JP)
- Tokyo Medical and Dental University (JP)
- LMU Klinikum (DE)
- Hôpital Necker-Enfants Malades (FR)
- Carolinas Healthcare System (US)
- Medical College of Wisconsin (US)
- Cincinnati Children's Hospital Medical Center (US)
- Duke Medical Center (US)
- University of South Carolina (US)
- Corresponding author
- Latour, Sylvain
- Rosenzweig, Sergio D.
- ORCID
- Boutboul, David
- Kuehn, Hye Sun
- Niemela, Julie E.
- Callebaut, Isabelle
- Stoddard, Jennifer
- Lenoir, Christelle
- Barlogis, Vincent
- Farnarier, Catherine
- Vely, Frédéric
- Yoshida, Nao
- Kojima, Seiji
- Kanegane, Hirokazu
- Hoshino, Akihiro
- Hauck, Fabian
- Lhermitte, Ludovic
- Asnafi, Vahid
- Chen, Shaoying
- Verbsky, James W.
- Calvo, Katherine R.
- Husami, Ammar
- Zhang, Kejian
- Roberts, Joseph
- Hsu, Amy P.
- Holland, Steven M.
- Marsh, Rebecca
- Fischer, Alain
- Fleisher, Thomas A.
- Picard, Capucine
- Latour, Sylvain
- Rosenzweig, Sergio D.
- Venue
- Journal of Clinical Investigation
- Published
- 2018-06-11
- Volume
- 128
- Issue
- 7
- Pages
- 3071-3087
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC6026000
- OpenAlex
- W2805128721
- Cited by
- 169
- References
- 45
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 21 · 2023: 23 · 2022: 19 · 2021: 30 · 2020: 30 · 2019: 19 · 2018: 3
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Agence Nationale de la Recherche, France (ANR-14-CE14-0028-01, ANR-10-IAHU-01)
- Ligue Contre le Cancer, France (Equipe Labellisée)
- Rare Diseases Fondation, France (Exome sequencing)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- IKZF1, Ikaros, dominant negative mutation, germline mutations, combined immunodeficiency, T cell deficiency, B-cell immunodeficiency, Pneumocystis carinii pneumonia, T-cell acute lymphoblastic leukemia, DNA-binding domain, haploinsufficiency, naive T cells, dendritic cells, monocyte dysfunction, neutrophil deficiency, B-cell acute lymphoblastic leukemia
- MeSH terms
- Protein Domains, Loss of Function Mutation, Adolescent, Adult, Amino Acid Sequence, B-Lymphocytes, Child, Child, Preschool, Female, Genes, Dominant, Heterozygote, Humans, Immunologic Deficiency Syndromes, Infant, Male, Pedigree, Phenotype, T-Lymphocytes, Sequence Homology, Amino Acid, Germ-Line Mutation, Amino Acid Substitution, Myeloid Cells, Ikaros Transcription Factor, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
